FEATURES

Alcon Completes Acquisition of Belkin Vision, Expands Glaucoma Portfolio

GENEVA—Global eyecare company Alcon has announced the closing of a deal to acquire Israel-based Belkin Vision, developer of a first-line glaucoma laser treatment, with a total upfront consideration of $81 million, including a cash payment of approximately $65 million.  Read more...


Silmo Prepares for 2024 Edition Focused on Optical’s Future

PARIS—Silmo 2024 organizers are preparing for this year’s edition, which will feature over 900 exhibitors and 1,500 brands from 144 countries, according to an announcement from show organizers.  Read more...


NovaBay Pharmaceuticals and Eyenovia Commence Co-Promotion Activities

EMERYVILLE, Calif. and NEW YORK—NovaBay Pharmaceuticals, Inc., a developer of eyecare, skin care and wound care products, and Eyenovia, Inc., a commercial-stage ophthalmic technology company with two FDA-approved products and a late-stage asset in pediatric progressive myopia, have commenced co-promotion activities under an agreement that was first announced in MarchRead more...


MOST READ STORIES

CURRENT
ISSUE

June 2024

June 2024

FEATURED COURSE

20/20 Pro to Pro Continuing Education